AtheroNova Inc. (AHRO.OB) Announces Q1 2014 Financial Results/Highlights
5/19/2014 9:39:17 AM
IRVINE, Calif., May 19, 2014 (GLOBE NEWSWIRE) -- AtheroNova Inc. (OTCBB:AHROD), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced its financial results for the fiscal quarter ended March 31, 2014 and provided a corporate update on operations and progress on lead candidate AHRO-001.
Help employers find you! Check out all the jobs and post your resume.
comments powered by